Fibrinogen Alpha Chain Precursor and Apolipoprotein A-I in Urine as Biomarkers for Noninvasive Diagnosis of Calcium Oxalate Nephrolithiasis: A Proteomics Study

Table 5

Identification of sequences of peptide differentially expressed between CaOx nephrolithiasis and healthy control.

m/z^a	Peptide name	Peptide sequences
1207.23	FGA isoform 1 of fibrinogen alpha chain precursor	G.EGDFLAEGGGVR.G
2773.86	apoA-1 apolipoprotein A-I precursor	L.PVLESFKVSFLSALEEYTKKLNTQ.-
6182.87	Uncharacterized peptide
2847.86	FGA isoform 1 of fibrinogen alpha chain precursor	S.SSYSKQFTSSTSYNRGDSTFESKSY.K
6295.88	Uncharacterized peptide
4754.38	Uncharacterized peptide
6131.83	Uncharacterized peptide
6083.70	Uncharacterized peptide
6069.56	Uncharacterized peptide
2830.18	TMSL3 thymosin beta-4-like protein 3	K.KTETQEKNPLPSKETIEQEKQAGES.-
6327.86	Uncharacterized peptide
2757.24	F13A1 coagulation factor XIII A chain precursor	R.RAVPPNNSNAAEDDLPTVELQGVVPR.G
2726.01	COPA coatomer subunit alpha	R.FWVLAAHPNLNLFAAGHDGGMIVFK.L

^am/z, average mass.